Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

Volume: 10, Issue: 1
Published: Aug 28, 2019
Abstract
Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion. The chronic inflammatory process contributed to IR and could also hamper pancreatic β cell function. However, currently applied treatment cannot reverse β cell damage or alleviate inflammation. Mesenchymal stem cells (MSCs), the cell-based therapy for their self-renewable, differentiation potential, and immunosuppressive properties,...
Paper Details
Title
Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
Published Date
Aug 28, 2019
Volume
10
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.